Advertisement
Clinical Research and Public HealthIn-Press PreviewCell biologyOncology
Open Access |
10.1172/JCI203289
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Huang, Z. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Wang, Z. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Liu, Y. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Shen, J. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Wu, Y. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Fang, Z. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Wu, D. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Cheng, Y. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Zhang, J. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Zou, X. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Ma, J. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Lv, J. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Wang, S. in: PubMed | Google Scholar
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Find articles by Chen, Y. in: PubMed | Google Scholar
Published November 17, 2026 - More info
BACKGROUND. Molecular subtyping may offer a promising path toward a unified framework for precision oncology. We sought to characterize the patterns of programmed cell death (PCD), a pivotal cellular process shaping both intrinsic tumor malignancy and the tumor microenvironment, to better understand tumor heterogeneity.
METHODS. We performed integrative multi-cohort transcriptomic analyses encompassing four canonical PCD modes across multiple cancer types. We identified PCD subtypes using nonnegative matrix factorization (NMF), characterized their molecular features and clinical relevance, and developed a streamlined 20-gene classifier to facilitate subtype assignment.
RESULTS. We identified five conserved PCD subtypes with distinct genomic alterations, cellular stresses, malignant traits, prognostic outcomes, and immune landscapes. In the immunotherapy setting, PCD subtypes were associated with distinct outcomes across multiple cancer types, with the pyroptosis-dominant (PCD-P) subtype showing the most favorable outcomes. The 20-gene classifier showed good discriminatory performance across independent cohorts. Finally, we proposed candidate subtype-specific therapeutic strategies.
CONCLUSION. This study establishes a comprehensive framework for characterizing PCD patterns in cancer, laying the groundwork for biomarker discovery and rational therapeutic design that warrant future evaluation of efficacy and toxicity.
FUNDING. National Key R&D Program of China; National Natural Science Foundation of China; Fundamental Research Funds for the Central Universities, Sun Yat-sen University; HE Science Foundation; Young Talents Program of Sun Yat-sen University Cancer Center; Academician Workstation of Jun Ma; Specific Research Fund of the Innovation Platform for Academicians of Hainan Province; Shenzhen Medical Research Fund; Guangdong Basic and Applied Basic Research Foundation.